FDA Approves First Targeted Therapy for IDH-Mutant Glioma with Companion Diagnostic

Targeting NBR1: New Biomarker Could Predict Immunotherapy Success in Liver Cancer

FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer

Sanofi and Orano Join Forces to Develop Novel Radioligand Therapies for Rare Cancers

AI-Powered Cancer Drug LP-184 Receives FDA Fast-Track Designation for Glioblastoma

How Engineered Oncolytic Adenoviruses Could Transform Cancer Treatment

FDA Approves Itovebi as First-Line Therapy for PIK3CA-Mutated Breast Cancer

Merlin Molecular Test Offers Hope for Melanoma Patients by Reducing Unnecessary Surgeries

The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment

Bayer Expands Precision Oncology Portfolio with MOMA Therapeutics' KNOMATIC Platform

The LUMINOSITY Trial And Exploring Novel Biomarker Targets in the Future of ADCs for NSCLC

The Future of Oncolytic Viruses and Their Role in Cancer Treatment

The Role of AI in the Future of Drug Discovery: Redefining Accuracy...

New AI Model VersAI™ Elevates AI Accuracy in Drug Discovery with Sparse Data

ESMO 2024: BRAFTOVI and MEKTOVI Extend Survival in Rare Mutant Lung Cancer

ESMO 2024: Novartis's Kisqali Reduces Breast Cancer Recurrence Risk by 28.5%

The OVATION 2 Study and the Novel Immunotherapy IMNN-001 for Ovarian Cancer

European Commission Approves BRAFTOVI and MEKTOVI for Lung Cancer

FDA Approves TruSight Cancer Test for Matching Patients with Targeted Therapies

FDA Approves Breakthrough Device: Altius System to Tackle Chronic Amputation Pain

Nipocalimab Submitted to FDA for Treatment of Generalized Myasthenia Gravis

Exploring The Potential of Cytokine Therapies to Transform Cancer Treatment

First Lung Cancer Vaccine Trial for BioNTech's BNT116 Launched Across 7 Countries

Next-Generation Weight Loss Therapeutic Nimacimab Enters Phase 2 Clinical Trial

Novel Cancer Drug PT217 Wins FDA Orphan Drug Status for Neuroendocrine Carcinoma

Lung Cancer Treatment for Never Smokers: The HARMONIC Phase 2 Trial and LP-300

Mixed-Reality System, HipInsight, Receives FDA Approval for Hip Surgery

AI-Powered Treatment Success: LP-300 Shows Promise for Non-Smoker Lung Cancer

FDA Approves Neffy: First Nasal Spray for Emergency Allergic Reactions

The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan